Ironwood Pharmaceuticals Q3 revenue was $133.04 million
IRWD•Ironwood Pharmaceuticals reported Q3 revenue of $133.04 million, adjusted EBITDA of $97.925 million, net income of $59.838 million and EPS of $0.36.
1. Q3 results
Ironwood Pharmaceuticals reported Q3 revenue of $133.04 million and adjusted EBITDA of $97.925 million. Net income was $59.838 million, adjusted net income was $60.045 million and basic and diluted EPS were both $0.36.
